金吾财讯 | Revvity(RVTY)盘前股价拉升，暂涨6.8%，报100.7美元。消息面上，得益于生物技术客户对用于药物研究的医疗设备的稳定需求，公司一季度调整后利润为每股 1.01 美元，高于分析师预期的每股 95 美分。一季度营收为 6.648 亿美元，略高于预期的 6.612 亿美元。该公司的生命科学部门为药物发现和开发提供试剂和仪器，其收入为 3.404 亿美元，而预期为 3.32 ...
Source Link金吾财讯 | Revvity(RVTY)盘前股价拉升，暂涨6.8%，报100.7美元。消息面上，得益于生物技术客户对用于药物研究的医疗设备的稳定需求，公司一季度调整后利润为每股 1.01 美元，高于分析师预期的每股 95 美分。一季度营收为 6.648 亿美元，略高于预期的 6.612 亿美元。该公司的生命科学部门为药物发现和开发提供试剂和仪器，其收入为 3.404 亿美元，而预期为 3.32 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.